Results 1 to 10 of about 11,492 (193)
Ecotoxicology and Environmental SafetyBackground: Metabolic dysfunction-associated fatty liver disease (MAFLD) and air pollution are both significant health concerns. However, their combined effects on multi-system morbidity and all-cause mortality remain poorly understood.
Jingyi Zhang +7 more
doaj +3 more sources
Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
EXCLI Journal : Experimental and Clinical Sciences, 2023 Non-alcoholic fatty liver disease (NAFLD) is a prevailing health challenge that requires urgent innovative interventions. This review explores the role of nanotechnology as a promising potential in the treatment of NAFLD. It delineates the limitations of
Atie Moghtadaie +3 more
doaj +1 more source
Hepatology, EarlyView., 2022 Graphical abstract summarizing the study design, main results and key findings Abstract Background and Aims Fatty liver disease (FLD) has been associated with excess mortality. Screening for hepatic steatosis (HS) in patients with metabolic dysfunction is therefore recommended by several guidelines, despite a paucity of evidence on the clinical ...
Laurens A. van Kleef +5 more
wiley +1 more source
Hepatology, EarlyView., 2022 Visualisation of the study desgin, main results and key findings. Abstract Background and Aims MAFLD often cooccurs with excessive alcohol consumption, while its prognostic value in this group remains unclear. We aimed to study the mortality risk of MAFLD in relation to excessive alcohol consumption and its potential interactions.
Laurens A. van Kleef +2 more
wiley +1 more source
The NAFLD–MAFLD debate through the lens of the Arab world
The Saudi Journal of Gastroenterology, 2022 The most common liver disease in the world is fatty liver disease related to metabolic dysfunction, yet neither patients nor medical professionals are fully aware of this.
Mina Tharwat +2 more
doaj +1 more source
Ожирение и метаболизм, 2021 The widespread prevalence of non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM), as well as their combination, determines the need for a targeted analysis of this pathology in order to optimize approaches to the diagnosis and ...
E. V. Kiseleva, T. Y. Demidova
doaj +1 more source
Gut and Liver, 2023 Background/Aims: Metabolic dysfunction-associated fatty liver disease (MAFLD) is categorized into three subtypes: overweight/obese (OW), lean/normal weight with metabolic abnormalities, and diabetes mellitus (DM).
Tae Seop Lim +7 more
doaj +1 more source
Exploration of Medicine, 2020 The prevalence of nonalcoholic or more recently re-defined metabolic associated fatty liver disease (MAFLD) is rapidly growing worldwide. It is characterized by hepatic fat accumulation exceeding 5% of liver weight not attributable to alcohol consumption.
Marica Meroni +2 more
doaj +1 more source
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseases [PDF]
Clinical and Molecular HepatologyMetabolic dysfunction-associated fatty liver disease (MAFLD) is an increasingly common liver disease worldwide. MAFLD is diagnosed based on the presence of steatosis on images, histological findings, or serum marker levels as well as the presence of at ...
Pin-Nan Cheng +24 more
doaj +1 more source
BMC Medicine, 2023 Background Metabolic-associated fatty liver disease (MAFLD) encompasses diverse disease groups with potentially heterogeneous clinical outcomes. We investigated the risk of all-cause and disease-specific mortality in MAFLD subgroups.
Goh Eun Chung +10 more
doaj +1 more source